Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010–2018: Experience from a tertiary diabetes center in Bangkok

Thewjitcharoen, Yotsapon; Butadej, Siriwan; Malidaeng, Areeya; Yenseung, Nalin; Nakasatien, Soontaree; Lekpittaya, Nampetch; Worawit, Kittipoom; Krittiyawong, Sirinate; Himathongkam, Thep

doi:10.1016/j.jcte.2020.100227

Cited by 10 publications

(10 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our observations on the associations between previous IV and PV, and more findings of several studies on prior PV and current PV, indicate that the patients who had received any kind of vaccination were likely to be more vigilant about disease prevention (37,38). The VRs in developed countries increased with the presence of CPD, a higher number of regular followup visits, and a longer duration of diabetes (25,38). Our findings regarding the relationship between comorbidities and vaccination status were consistent with the literature.…”

Section: Discussionmentioning

confidence: 54%

“…On the other hand, most of our patients who were vaccinated against one of the infectious agents were observed to have received other recommended vaccines, implying an enhancement in awareness for vaccination. Our observations on the associations between previous IV and PV, and more findings of several studies on prior PV and current PV, indicate that the patients who had received any kind of vaccination were likely to be more vigilant about disease prevention (37,38). The VRs in developed countries increased with the presence of CPD, a higher number of regular followup visits, and a longer duration of diabetes (25,38).…”

Section: Discussionmentioning

confidence: 55%

See 1 more Smart Citation

Evaluation of Influenza, Pneumococcus, Zoster, Measles, Diphtheria, and Pertussis Vaccination Rates in Patients with Type 1 and Type 2 Diabetes Mellitus; a Single-Center Experience From Turkey

Yeşilova¹,

Bilge²,

Özsoy³

et al. 2021

Turk J Endocrinol Metab

View full text Add to dashboard Cite

Objective: Several vaccines have been recommended for adults with diabetes. This study aimed to determine the rates of uptake of recommended vaccines in diabetic adults and estimate their association with sociodemographic and clinical factors. Material and Methods: This was a cross-sectional study conducted on patients with either type 1 or type 2 diabetes, who had attended the outpatient clinics of internal medicine and endocrinology. The patients were inquired about their immunization status against influenza, pneumococcus, zoster, measles, pertussis, and diphtheria. Results: Among the 350 diabetic patients, 38 (10.8%) had received a vaccine against pneumococcus, 90 (26%) against seasonal influenza, and only one patient had been administered the zoster vaccine. None of the patients had been vaccinated against measles, diphtheria, and pertussis. The rate of pneumococcal vaccination (PV) increased with age (65.5±9.7 vs. 57±9.1 [OR 2.9 (95% CI=14.3-2.67], p=0.005), although there was no such association between influenza vaccination (IV) and age (p=0.456). The rate of PV increased with the number of routine follow-up visits per year (10/38 vs. 28/38 [4][5][6][7][8][9][10][11][12][13][14][15][16].096], (p=0.039). The rates of PV and IV were significantly higher in diabetic patients with chronic pulmonary disease (21/38 vs. 14/312 ], p=0.001) respectively. The rates of IV in diabetic patients with chronic renal failure were also significantly different from those without (27/90 vs. 8/260, [OR 14.28 95% CI 1.51-133.74], p=0.013). Conclusion: We observed low rates of vaccination against influenza, pneumococcus, and zoster in patients with diabetes, which were below the targets recommended by the World Health Organization.

show abstract

Section: Discussionmentioning

confidence: 54%

Section: Discussionmentioning

confidence: 55%

Evaluation of Influenza, Pneumococcus, Zoster, Measles, Diphtheria, and Pertussis Vaccination Rates in Patients with Type 1 and Type 2 Diabetes Mellitus; a Single-Center Experience From Turkey

Yeşilova¹,

Bilge²,

Özsoy³

et al. 2021

Turk J Endocrinol Metab

View full text Add to dashboard Cite

show abstract

“…But the overall vaccination rates are not at the desired levels in many countries. Studies in different populations reported influenza vaccination rates between 40% and 60%[ 12 , 23 - 25 ]. In terms of pneumococcal vaccine, the situation is slightly worse, and the rate of vaccination in various countries varies between 18% and 53% in patients with diabetes[ 26 - 28 ].…”

Section: Discussionmentioning

confidence: 99%

Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study)

Demirci¹,

Haymana²,

Salman³

et al. 2021

WJD

View full text Add to dashboard Cite

BACKGROUND Vaccination against influenza and pneumococcus is effective in reducing morbidity and mortality in patients with diabetes. AIM To investigate the prevalence of influenza and pneumococcal vaccinations and to search for the independent associates of vaccination in Turkish patients with diabetes. METHODS In this cross-sectional, nationwide, multicenter study, adult patients with type 1 diabetes (T1DM) ( n = 454) and type 2 diabetes (T2DM) ( n = 4721), who were under follow-up for at least a year in the outpatient clinics, were consecutively enrolled. Sociodemographic, clinical, and laboratory parameters of patients were recorded. Vaccination histories were documented according to the self-statements of the patients. RESULTS Patients with T1DM and T2DM had similar vaccination rates for influenza (23.6% vs 21.2%; P = 0.240) and pneumococcus (8% vs 7%; P = 0.451) vaccinations. Longer diabetes duration and older age were the common independent associates of having vaccination for both types of diabetes patients. Higher education level, using statin treatment, and having optimal hemoglobin A1c levels were the common independent associates of influenza and pneumococcal vaccination in patients with T2DM. CONCLUSION TEMD Vaccination Study shows that patients with T1DM and T2DM had very low influenza and pneumococcal vaccination rates in Turkey. The lower rates of vaccination in certain populations urges the necessity of nationwide vaccination strategies targeting these populations.

show abstract

“…18 In another study from a tertiary care diabetes center in Thailand, the overall vaccination rate was 17.4% for the pneumococcal vaccine. 19 A study conducted by Akihiro Sakamoto of club members in Miyakonojo city, Japan stated that the pneumococcal vaccination rate was 53.2%. 20 Another study conducted in Australia among general populations in above 65 years age group revealed that PCV coverage was 36% among 65-74 years age group.…”

Section: Discussionmentioning

confidence: 99%

Utility of pneumococcal vaccine among elderly population in buraidah primary health care centers

Alawaji

Kalevaru

2021

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: People with chronic diseases tend to land up with high mortality and morbidity. Objective of the study is to determine the prevalence of Pneumococcal vaccine utility among the 50 years and above age group population, to find the demographic profile, the knowledge of PCV among the general population.Methods: A cross-sectional study was conducted randomly in 6 primary health care centers in Buraidah city, Saudi Arabia from the aged 50 years and above population. Sample size was calculated by using WHO statistical software for sample size determination, the result of sample size was 236 participants. A interview-based questionnaire was used after obtaining consent from each participant. Data entered and analyzed using the SPSS software 21.0 version. For categorical analysis, chi square test was applied.Results: In the present study, a total of 202 samples of the population has participated and response rate was 86%. About only 12.9% (26/202) of study population taken PCV vaccine in the study. About 79.7% were having different chronic diseases. About 83.7% were given a response as PCV prevents the disease. There was statistically significant association was observed between different levels of education and chronic heart disease with PCV vaccination status (p<0.05).Conclusions: Based on the study results, Pneumococcal vaccination coverage was low, in comparison with Riyadh study in 2018; our study vaccination coverage was more. Still need Health promotional measures among the general public to increase the coverage of PCV.

show abstract

Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010–2018: Experience from a tertiary diabetes center in Bangkok

Cited by 10 publications

References 33 publications

Evaluation of Influenza, Pneumococcus, Zoster, Measles, Diphtheria, and Pertussis Vaccination Rates in Patients with Type 1 and Type 2 Diabetes Mellitus; a Single-Center Experience From Turkey

Evaluation of Influenza, Pneumococcus, Zoster, Measles, Diphtheria, and Pertussis Vaccination Rates in Patients with Type 1 and Type 2 Diabetes Mellitus; a Single-Center Experience From Turkey

Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study)

Utility of pneumococcal vaccine among elderly population in buraidah primary health care centers

Contact Info

Product

Resources

About